INTRODUCTION: Noninvasive methods are needed to detect distal sensory polyneuropathy in HIV-infected persons on antiretroviral therapy (ART). METHODS: Quantitative sudomotor axon reflex test (QSART) and Utah Early Neuropathy Scale (UENS), small-fiber sensitive measures, were assessed in subjects with and without clinical neuropathy. Pain was assessed by visual analog scale (VAS). RESULTS: Twenty-two subjects had symptoms and signs of neuropathy, 19 had neither, and all were receiving ART. Median sweat volume (μL) was lower at all testing sites in those with neuropathy compared to those without (p<0.01 for all). UENS and VAS (mm) were higher in neuropathy subjects (p<0.05 for each). Lower sweat volume at all sites correlated with higher pin UENS subscore, total UENS, and VAS (p<0.05 for all). In multivariable analyses adjusting for age, CD4⁺ T cells, sex, and use of "d-drug" ART, QSART and UENS remained associated (p=0.003). CONCLUSION: QSART and UENS have not been previously studied in this patient population and may identify small-fiber neuropathy in HIV-infected, ART-treated persons.
INTRODUCTION: Noninvasive methods are needed to detect distal sensory polyneuropathy in HIV-infected persons on antiretroviral therapy (ART). METHODS: Quantitative sudomotor axon reflex test (QSART) and Utah Early Neuropathy Scale (UENS), small-fiber sensitive measures, were assessed in subjects with and without clinical neuropathy. Pain was assessed by visual analog scale (VAS). RESULTS: Twenty-two subjects had symptoms and signs of neuropathy, 19 had neither, and all were receiving ART. Median sweat volume (μL) was lower at all testing sites in those with neuropathy compared to those without (p<0.01 for all). UENS and VAS (mm) were higher in neuropathy subjects (p<0.05 for each). Lower sweat volume at all sites correlated with higher pin UENS subscore, total UENS, and VAS (p<0.05 for all). In multivariable analyses adjusting for age, CD4⁺ T cells, sex, and use of "d-drug" ART, QSART and UENS remained associated (p=0.003). CONCLUSION: QSART and UENS have not been previously studied in this patient population and may identify small-fiber neuropathy in HIV-infected, ART-treated persons.
Authors: V Novak; M L Freimer; J T Kissel; Z Sahenk; I M Periquet; S M Nash; M P Collins; J R Mendell Journal: Neurology Date: 2001-04-10 Impact factor: 9.910
Authors: M Polydefkis; C T Yiannoutsos; B A Cohen; H Hollander; G Schifitto; D B Clifford; D M Simpson; D Katzenstein; S Shriver; P Hauer; A Brown; A B Haidich; L Moo; J C McArthur Journal: Neurology Date: 2002-01-08 Impact factor: 9.910
Authors: M I Periquet; V Novak; M P Collins; H N Nagaraja; S Erdem; S M Nash; M L Freimer; Z Sahenk; J T Kissel; J R Mendell Journal: Neurology Date: 1999-11-10 Impact factor: 9.910
Authors: D M Simpson; G Schifitto; D B Clifford; T K Murphy; E Durso-De Cruz; P Glue; E Whalen; B Emir; G N Scott; R Freeman Journal: Neurology Date: 2010-02-02 Impact factor: 9.910
Authors: W Singer; J M Spies; J McArthur; J Low; J W Griffin; K K Nickander; V Gordon; P A Low Journal: Neurology Date: 2004-02-24 Impact factor: 9.910
Authors: Su-Bo Yuan; Yuqiang Shi; Jinghong Chen; Xiangfu Zhou; Guangyu Li; Benjamin B Gelman; Joshua G Lisinicchia; Susan M Carlton; Monique R Ferguson; Alai Tan; Sushil K Sarna; Shao-Jun Tang Journal: Ann Neurol Date: 2014-05-28 Impact factor: 10.422
Authors: Dominic Chow; Beau K Nakamoto; Katherine Sullivan; David M Sletten; Satomi Fujii; Sari Umekawa; Morgan Kocher; Kalpana J Kallianpur; Cecilia M Shikuma; Phillip Low Journal: Open Forum Infect Dis Date: 2015-07-08 Impact factor: 3.835